A detailed history of Reston Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Reston Wealth Management LLC holds 1,440 shares of ABBV stock, worth $241,992. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,440
Previous 1,527 5.7%
Holding current value
$241,992
Previous $236,000 11.02%
% of portfolio
0.11%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $13,904 - $15,842
-87 Reduced 5.7%
1,440 $262,000
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $210,115 - $236,639
1,527 New
1,527 $236,000
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $688 - $874
5 Added 0.33%
1,514 $232,000
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $3,695 - $4,585
28 Added 1.89%
1,509 $245,000
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $159,103 - $201,312
1,481 New
1,481 $201,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Reston Wealth Management LLC Portfolio

Follow Reston Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reston Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reston Wealth Management LLC with notifications on news.